[Effect of cerebrolysin on remyelination processes in multiple sclerosis patients in stage of relapse regression].
Khabirov FA, Khaybullin TI, Granatov EV, Shakirzianova SR · 2016 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
What does this source report?
No between-group EDSS difference was reported; selected functional and neurophysiological measures differed.
- Population and setting
- 40 patients during regression of a multiple-sclerosis relapse after steroid treatment
- Evidence type
- Randomized trial
- Preparation
- Porcine brain-derived peptide mixture; equivalence to other hydrolysates is not assumed
- Source language
- Indexed English abstract; original language varies
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Short follow-up, attrition and a very small MRI subset limit interpretation. Surrogate changes do not establish remyelination.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Citation and indexed abstract checked. Full methods, funding and risk of bias have not been comprehensively appraised.
Recorded source-check date: 2026-09-30. This date does not imply a completed systematic review.
Source provenance: Journal publication
Cite and trace this record
Original source: Khabirov FA, Khaybullin TI, Granatov EV, Shakirzianova SR. [Effect of cerebrolysin on remyelination processes in multiple sclerosis patients in stage of relapse regression]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2016.
Molekul research summary: https://molekul.io/research/cbl-28139626. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry